Impedimed Ltd (ASX:IPD)
A$ 0.053 0 (0%) Market Cap: 107.22 Mil Enterprise Value: 83.73 Mil PE Ratio: 0 PB Ratio: 2.65 GF Score: 0/100

Q1 2021 ImpediMed Ltd Earnings Call Transcript

Oct 26, 2020 / 10:15PM GMT
Release Date Price: A$0.083 (+2.47%)
Operator

Thank you for standing by, and welcome to the ImpediMed quarterly results investor conference call. (Operator Instructions)

I would now like to hand the conference over to Mr. Richard Carreon, Managing Director and CEO. Please go ahead.

Richard Carreon
ImpediMed Limited - MD, CEO, President & Executive Director

Thank you, Rachel. Welcome, everyone, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending 30 September, 2020.

With us on the call this afternoon is Tim Cruickshank, our Chief Financial Officer; and Mike Bassett, our Senior Vice President of Corporate and Strategic Development.

I'll be referencing the 4C we lodged this morning, Australian time. At the conclusion of my remarks, we'll be taking questions.

Today, we'll be discussing our first quarter results for 2021 financial year. We have made great strides over the quarter, and we are confident that the key drivers are in place to accelerate the adoption of the SOZODigital Health Platform over

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot